Scout Investments’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-614,307
Closed -$2.21M 209
2023
Q3
$2.21M Sell
614,307
-17,829
-3% -$64.2K 0.05% 209
2023
Q2
$2.86M Sell
632,136
-18,814
-3% -$85.2K 0.06% 208
2023
Q1
$4.45M Sell
650,950
-7,688
-1% -$52.6K 0.09% 190
2022
Q4
$5.22M Sell
658,638
-10,748
-2% -$85.1K 0.11% 185
2022
Q3
$6.43M Sell
669,386
-18,940
-3% -$182K 0.13% 175
2022
Q2
$4.98M Buy
688,326
+92,739
+16% +$671K 0.1% 192
2022
Q1
$7.69M Sell
595,587
-773
-0.1% -$9.98K 0.12% 181
2021
Q4
$9.52M Sell
596,360
-13,378
-2% -$214K 0.14% 193
2021
Q3
$9.8M Sell
609,738
-15,831
-3% -$254K 0.15% 195
2021
Q2
$8.65M Buy
625,569
+74,618
+14% +$1.03M 0.13% 210
2021
Q1
$8.05M Buy
+550,951
New +$8.05M 0.12% 234